Royalty Pharma plc
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2018 | 30.3% | 30.3% | — |
| FY2019 | 38.2% | 19.4% | 18.9% |
| FY2020 | 9.9% | 6.2% | 6.1% |
| FY2021 | 6.0% | 3.6% | 3.5% |
| FY2022 | 0.4% | 0.3% | 0.3% |
| FY2023 | 11.3% | 7.0% | 6.9% |
| FY2024 | 8.3% | 5.1% | 4.7% |
| FY2025 | 7.9% | 4.2% | 3.9% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2018 | 30.3% | 30.3% | — |
| FY2019 | 38.2% | 19.4% | 18.9% |
| FY2020 | 9.9% | 6.2% | 6.1% |
| FY2021 | 6.0% | 3.6% | 3.5% |
| FY2022 | 0.4% | 0.3% | 0.3% |
| FY2023 | 11.3% | 7.0% | 6.9% |
| FY2024 | 8.3% | 5.1% | 4.7% |
| FY2025 | 7.9% | 4.2% | 3.9% |